Kongtim, P., Adekola, K., Milton, D. R., Ramlal, R., Jimenez, A., Chen, J., . . . Ciurea, S. O. (2017). Donor type, in Addition to Transplantation in Chronic Phase and Myeloablative Conditioning, Influence Transplant Survival for Patients with Advanced Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors. Leukemia.
Chicago Style CitationKongtim, Piyanuch, et al. "Donor Type, in Addition to Transplantation in Chronic Phase and Myeloablative Conditioning, Influence Transplant Survival for Patients With Advanced Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors." Leukemia 2017.
Cita MLAKongtim, Piyanuch, et al. "Donor Type, in Addition to Transplantation in Chronic Phase and Myeloablative Conditioning, Influence Transplant Survival for Patients With Advanced Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors." Leukemia 2017.